SIGNAL TRANSDUCTION IN DIFFUSE INTRINSIC PONTINE GLIOMA
July 2019 marked the Dun Lab’s first publication in the field of DIPG research, an exciting achievement for any researcher but particularly of note given Dr Dun’s recent entry to this field and the quality of the journal accepting the manuscript. Proteomics is the premier international source on all things ‘-omics’, the technologies used to study the roles and relationships of molecules comprising the cells of a living organism. Examples include genomics (genes and their function), metabolomics (components of cell metabolism) and that which Dr Dun’s group specialise in- proteomics- the study of proteins encoded by the genes of a living cell, tissue or whole organism.
Despite decades passing since the formal classification of DIPG, very little is known as to the mechanisms allowing continued growth and survivability of DIPG tumours. Titled ‘Signal transduction in diffuse intrinsic pontine glioma,’ Dr Dun and the Cancer Signalling Research Group summarise what is known and highlight the opportunity for high‐resolution quantitative proteomics to characterise specific signalling cascades errant in DIPG.
Read the publication here: SIGNAL TRANSDUCTION IN DIFFUSE INTRINSIC PONTINE GLIOMA